rejuvant life tabs

Can CRISPR be used to diagnose aging?

Latest articles

A single source for longevity nutrition data

Edamam co-founder talks bringing nutrition into the digital world and seeking funding for expansion in food as medicine. When it comes to food nutrition data,...

The Sheekey Science Show – Senotherapeutics

Senotherapeutics are therapeutics strategies that target cellular senescence. They can work by killing senescent cells (senolytics), inhibiting the proinflammatory secretory phenotype of senescent cells (senomorphics)...

Michael Greve commits €300m for rejuvenation start-ups

The founder of Forever Healthy has committed €300 million to advance rejuvenation biotech start-ups – plus exclusive insights from Michael Greve. Michael Greve, founder of...

Capsida Biotherapeutics emerges from stealth with $140m

Versant Ventures and Westlake Village BioPartners launch next-generation gene therapy company with $50m series A; AbbVie collaboration provides $90m for gene therapies for CNS...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...
Supplement report

Editor's picks

A single source for longevity nutrition data

Edamam co-founder talks bringing nutrition into the digital world and seeking funding for expansion in food as medicine. When it comes to food nutrition data,...

The Sheekey Science Show – Senotherapeutics

Senotherapeutics are therapeutics strategies that target cellular senescence. They can work by killing senescent cells (senolytics), inhibiting the proinflammatory secretory phenotype of senescent cells (senomorphics)...

Michael Greve commits €300m for rejuvenation start-ups

The founder of Forever Healthy has committed €300 million to advance rejuvenation biotech start-ups – plus exclusive insights from Michael Greve. Michael Greve, founder of...
Rejuvant

Irina Conboy talks CRISPR and how the gene-editing tech may have a significant role to play in diagnostics.

In the first article from our interview with Professor Irina Conboy, we covered the work for which she is most renowned – the study of factors in our blood that may impact on aging. But another key area of her lab’s research is CRISPR technologies, including playing a role the development of a CRISPR-powered device, which was recently the subject of a new paper highlighting its advanced capabilities in disease-detection.

Longevity.Technology: Much of the discussion around CRISPR-Cas9 technology focuses on its potential to treat a wide range of diseases by editing our DNA. But, while gene therapies leveraging CRISPR are probably still quite far from the clinic, Prof Conboy believes there are near-term opportunities for the technology in a diagnostic capacity.

“CRISPR is a seminal Nobel Prize discovery, but, in my opinion, it’s not easily scalable, or directly applicable to the clinic because it relies on gene therapy and works most effectively only in dividing cells,” she says. “So, until we make more progress in the fields that support CRISPR medicine, this approach is unlikely to be broadly and quickly used as a therapy for editing genes in people.”

CRISPR as a diagnostic tool

But Conboy thinks CRISPR could be used much sooner in diagnostic medicine.

“For example, a bedside diagnostic telling the doctors if the treatment that they’re prescribing is working – or to identify what’s going on with proteins and cells in the blood from tiny samples,” she says. “I believe it will also be able to predict the biomarkers of aging and disease, and we are working collaboratively on this with a rising star in this field, Professor Kiana Aran.”

Conboy attributes her journey into CRISPR to the fact she works at UC Berkeley, which she calls the “best college of engineering in the world.”

“I have this luxury that various professors come to me with their innovations to see if I have any systems to test them on.”

It was one of these approaches that first led to a collaboration with Professor Niren Murthy and Kunwoo Lee and the development of a new nanoparticle delivery system called CRISPR-Gold, which was shown to be able to repair disease mutations in mice.

“So we became experts in nanoparticles and CRISPR technology and then Kiana Aran decided to take it to the next step, which was can we use CRISPR for diagnostic purposes?” says Conboy, who joined forces with several others, including her former postdoc Aran, who now has her own lab at the Keck Graduate Institute.

Elevant

CRISPR-Chip technology

The collaboration led to the development of a hardware device, called CRISPR-Chip, using electronic transistors made from graphene to detect genetic mutations in minutes.

“Together we published a paper on using CRISPR to profile a person’s genome and to identify potential mutations very rapidly and accurately in a digital screen,” says Conboy. “So you basically have a precise digital output that tells you if a certain gene is mutated or not.”

DNA samples are placed on the chip, and myriad CRISPR molecules scan them for specific mutations, based on the homology between the gene of interest and the guide RNA. If CRISPR binds with the target, it creates a change in electrical charge that is detected by the device very sensitively and in real time.

“We started out looking for big changes, such as deletions or duplications in genomic DNA, but the next frontier was to detect even a single point mutation, which is the nature of many human diseases, as well as viral mutations. And that’s the focus of Kiana’s latest paper, which was published with our involvement.”

CRISPR’s diagnostic potential in aging

While this technology can be broadly applied across several fields, Conboy says that it can play a role in driving our understanding of aging and rejuvenation as well.

“There are many things that are linked to changes in genomic DNA and aging that are traditionally very difficult to profile because of the complexity of the assays required, a lack of good instruments, and the noisiness of results,” she says. “A digital device that quickly identifies DNA damage and mutations from a small blood sample would be revolutionary.”

While this is clearly still work in progress, Conboy expects that the future will see CRISPR technology deployed in consumer applications.

Elevant

“In the next 10 years, people might have wearable devices that tell them it’s time to go for another therapeutic plasma exchange, because you’re experiencing drifts in blood proteins and blood cells’ genome,” she predicts.

Image courtesy of Cardea Bio

Comment on this article

Danny Sullivan
Contributing Editor Danny has worked in technology communications for more than 15 years, spanning Europe and North America. From bionics and lasers to software and pharmaceuticals – and everything in between – he’s covered it all. Danny has wide experience of technology publishing and technical writing and has specific interest in the transfer from idea to market.
Rejuvant

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

JUVICELL sets sights on lifespan and healthspan

Ten ingredients, one capsule. JUVICELL is on a mission to deliver an all-in-one longevity supplement. Far from just supplementing their diet to ensure an adequate...

Is nicotinamide riboside a safe and effective way to combat aging?

ChromaDex executive highlights the importance of clinical studies to prove the benefits of NAD+ boosting compound. ChromaDex is the company behind the popular healthy aging...
Supplement report

Related articles

Young blood to old – where do the answers to aging lie?

Irina Conboy talks parabiosis, plasma dilution, and why young blood may not hold the all answers. When it comes to scientific research in the world...

Enzymes show interconnectivity of Parkinson’s and diabetes

Parkinson's and Type 2 diabetes share a key element that drives disease – and metformin might help both. Parkin is a protein coded by the...

Cellino: longevity powered by AI, stem cells & democracy

From a serendipitous meeting of minds to laser-enabled precision, Cellino is leveraging AI and pluripotent stem cells for longevity. We speak to CEO and...

Paving the way to future organ factories

Extracellular matrix obtained by controlled decellularisation is used to reconstruct the liver with human-like characteristics, paving the way for transplantable livers. Researchers at the Human...

Renal fibrosis caused by telomere shortening – new research

CNIO researchers demonstrate that renal fibrosis is caused by telomere shortening, paving the way for future treatment. Researchers in the Telomeres and Telomerase Group at...
Supps report ad middle